Bingshu Wu, Hongzhi Zheng, Jianqiu Gu, Yan Guo, Yixuan Liu, Yingfang Wang, Feng Chen, Aolin Yang, Jiabei Wang, Hailong Wang, Ying Liu, Difei Wang. J Diabetes Investig 2019
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
Renal transport of uric acid: evolving concepts and uncertainties.
Ion Alexandru Bobulescu, Orson W Moe. Adv Chronic Kidney Dis 2012
Ion Alexandru Bobulescu, Orson W Moe. Adv Chronic Kidney Dis 2012
40
The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial.
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. Expert Opin Pharmacother 2017
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. Expert Opin Pharmacother 2017
40
Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus.
Hala Ahmadieh, Sami Azar. Diabetes Technol Ther 2017
Hala Ahmadieh, Sami Azar. Diabetes Technol Ther 2017
40
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials.
Yumo Zhao, Lubin Xu, Dongli Tian, Peng Xia, Hua Zheng, Li Wang, Limeng Chen. Diabetes Obes Metab 2018
Yumo Zhao, Lubin Xu, Dongli Tian, Peng Xia, Hua Zheng, Li Wang, Limeng Chen. Diabetes Obes Metab 2018
40
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Julio Rosenstock, Alice Cheng, Robert Ritzel, Zsolt Bosnyak, Christine Devisme, Anna M G Cali, Jochen Sieber, Peter Stella, Xiangling Wang, Juan P Frías,[...]. Diabetes Care 2018
Julio Rosenstock, Alice Cheng, Robert Ritzel, Zsolt Bosnyak, Christine Devisme, Anna M G Cali, Jochen Sieber, Peter Stella, Xiangling Wang, Juan P Frías,[...]. Diabetes Care 2018
40
Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.
Wenjia Yang, Xiaoling Cai, Xueying Gao, Yifei Chen, Ling Chen, Linong Ji. J Diabetes Investig 2018
Wenjia Yang, Xiaoling Cai, Xueying Gao, Yifei Chen, Ling Chen, Linong Ji. J Diabetes Investig 2018
40
Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
Huilin Tang, Wei Cui, Dandan Li, Tiansheng Wang, Jingjing Zhang, Suodi Zhai, Yiqing Song. Diabetes Obes Metab 2017
Huilin Tang, Wei Cui, Dandan Li, Tiansheng Wang, Jingjing Zhang, Suodi Zhai, Yiqing Song. Diabetes Obes Metab 2017
40
Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience.
Alessandro Scorsone, Gabriella Saura, Mattia Fleres, Lucia Spano, Vito Aiello, Davide Brancato, Anna Di Noto, Francesca Provenzano, Vincenzo Provenzano. J Diabetes Res 2018
Alessandro Scorsone, Gabriella Saura, Mattia Fleres, Lucia Spano, Vito Aiello, Davide Brancato, Anna Di Noto, Francesca Provenzano, Vincenzo Provenzano. J Diabetes Res 2018
50
Chronic hyperuricemia, uric acid deposit and cardiovascular risk.
Davide Grassi, Livia Ferri, Giovambattista Desideri, Paolo Di Giosia, Paola Cheli, Rita Del Pinto, Giuliana Properzi, Claudio Ferri. Curr Pharm Des 2013
Davide Grassi, Livia Ferri, Giovambattista Desideri, Paolo Di Giosia, Paola Cheli, Rita Del Pinto, Giuliana Properzi, Claudio Ferri. Curr Pharm Des 2013
20
Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.
Michiaki Fukui, Muhei Tanaka, Emi Shiraishi, Ichiko Harusato, Hiroko Hosoda, Mai Asano, Mayuko Kadono, Goji Hasegawa, Toshikazu Yoshikawa, Naoto Nakamura. Metabolism 2008
Michiaki Fukui, Muhei Tanaka, Emi Shiraishi, Ichiko Harusato, Hiroko Hosoda, Mai Asano, Mayuko Kadono, Goji Hasegawa, Toshikazu Yoshikawa, Naoto Nakamura. Metabolism 2008
20
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.
Clifford J Bailey, Jorge L Gross, Anne Pieters, Arnaud Bastien, James F List. Lancet 2010
Clifford J Bailey, Jorge L Gross, Anne Pieters, Arnaud Bastien, James F List. Lancet 2010
20
Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.
Eiichi Araki, Yukiko Onishi, Michiko Asano, Hyosung Kim, Ella Ekholm, Eva Johnsson, Toshitaka Yajima. J Diabetes Investig 2016
Eiichi Araki, Yukiko Onishi, Michiko Asano, Hyosung Kim, Ella Ekholm, Eva Johnsson, Toshitaka Yajima. J Diabetes Investig 2016
20
Management of diabetes and hyperglycemia in hospitals.
Stephen Clement, Susan S Braithwaite, Michelle F Magee, Andrew Ahmann, Elizabeth P Smith, Rebecca G Schafer, Irl B Hirsch. Diabetes Care 2004
Stephen Clement, Susan S Braithwaite, Michelle F Magee, Andrew Ahmann, Elizabeth P Smith, Rebecca G Schafer, Irl B Hirsch. Diabetes Care 2004
20
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.
Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal, Traci A Mansfield, James F List. BMC Med 2013
Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal, Traci A Mansfield, James F List. BMC Med 2013
20
Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population.
Stephen P Juraschek, Mara McAdams-Demarco, Edgar R Miller, Allan C Gelber, Janet W Maynard, James S Pankow, Hunter Young, Josef Coresh, Elizabeth Selvin. Am J Epidemiol 2014
Stephen P Juraschek, Mara McAdams-Demarco, Edgar R Miller, Allan C Gelber, Janet W Maynard, James S Pankow, Hunter Young, Josef Coresh, Elizabeth Selvin. Am J Epidemiol 2014
20
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.
Michael A Nauck, Stefano Del Prato, Juris J Meier, Santiago Durán-García, Katja Rohwedder, Martina Elze, Shamik J Parikh. Diabetes Care 2011
Michael A Nauck, Stefano Del Prato, Juris J Meier, Santiago Durán-García, Katja Rohwedder, Martina Elze, Shamik J Parikh. Diabetes Care 2011
20
Serum uric acid levels and the risk of type 2 diabetes: a prospective study.
Vidula Bhole, Jee Woong J Choi, Sung Woo Kim, Mary de Vera, Hyon Choi. Am J Med 2010
Vidula Bhole, Jee Woong J Choi, Sung Woo Kim, Mary de Vera, Hyon Choi. Am J Med 2010
20
Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006.
Lauren F Loeffler, Ana Navas-Acien, Tammy M Brady, Edgar R Miller, Jeffrey J Fadrowski. Hypertension 2012
Lauren F Loeffler, Ana Navas-Acien, Tammy M Brady, Edgar R Miller, Jeffrey J Fadrowski. Hypertension 2012
20
Dapagliflozin for the treatment of type 2 diabetes.
Muhammad A Abdul-Ghani, Ralph A DeFronzo. Expert Opin Pharmacother 2013
Muhammad A Abdul-Ghani, Ralph A DeFronzo. Expert Opin Pharmacother 2013
20
Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status, practice variation, and barriers to implementation.
Curtiss B Cook, Beth Elias, Gail L Kongable, Daniel J Potter, Katherine M Shepherd, David McMahon. Endocr Pract 2010
Curtiss B Cook, Beth Elias, Gail L Kongable, Daniel J Potter, Katherine M Shepherd, David McMahon. Endocr Pract 2010
20
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.
Ele Ferrannini, Silvia Jimenez Ramos, Afshin Salsali, Weihua Tang, James F List. Diabetes Care 2010
Ele Ferrannini, Silvia Jimenez Ramos, Afshin Salsali, Weihua Tang, James F List. Diabetes Care 2010
20
Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes.
Tianshu Han, Xing Meng, Ruiqi Shan, Tianqi Zi, Yingmei Li, Hao Ma, Yanhe Zhao, Dan Shi, Rongge Qu, Xiaoyu Guo,[...]. Int J Obes (Lond) 2018
Tianshu Han, Xing Meng, Ruiqi Shan, Tianqi Zi, Yingmei Li, Hao Ma, Yanhe Zhao, Dan Shi, Rongge Qu, Xiaoyu Guo,[...]. Int J Obes (Lond) 2018
20
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes.
Qin Li, Zhen Yang, Bin Lu, Jie Wen, Zi Ye, Lili Chen, Min He, Xiaoming Tao, Weiwei Zhang, Ying Huang,[...]. Cardiovasc Diabetol 2011
Qin Li, Zhen Yang, Bin Lu, Jie Wen, Zi Ye, Lili Chen, Min He, Xiaoming Tao, Weiwei Zhang, Ying Huang,[...]. Cardiovasc Diabetol 2011
20
The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.
Siguang Li, Serena Sanna, Andrea Maschio, Fabio Busonero, Gianluca Usala, Antonella Mulas, Sandra Lai, Mariano Dei, Marco Orrù, Giuseppe Albai,[...]. PLoS Genet 2007
Siguang Li, Serena Sanna, Andrea Maschio, Fabio Busonero, Gianluca Usala, Antonella Mulas, Sandra Lai, Mariano Dei, Marco Orrù, Giuseppe Albai,[...]. PLoS Genet 2007
20
Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis.
Shuai Yu, Ying Chen, Xu Hou, Donghua Xu, Kui Che, Changgui Li, Shengli Yan, Yangang Wang, Bin Wang. Mol Neurobiol 2016
Shuai Yu, Ying Chen, Xu Hou, Donghua Xu, Kui Che, Changgui Li, Shengli Yan, Yangang Wang, Bin Wang. Mol Neurobiol 2016
20
Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study.
Eswar Krishnan, Bhavik J Pandya, Lorinda Chung, Ali Hariri, Omar Dabbous. Am J Epidemiol 2012
Eswar Krishnan, Bhavik J Pandya, Lorinda Chung, Ali Hariri, Omar Dabbous. Am J Epidemiol 2012
20
Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study.
Zixuan Deng, Yunjuan Gu, Xuhong Hou, Lei Zhang, Yuqian Bao, Cheng Hu, Weiping Jia. Diabetes Metab Res Rev 2016
Zixuan Deng, Yunjuan Gu, Xuhong Hou, Lei Zhang, Yuqian Bao, Cheng Hu, Weiping Jia. Diabetes Metab Res Rev 2016
20
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.
James F List, Vincent Woo, Enrique Morales, Weihua Tang, Fred T Fiedorek. Diabetes Care 2009
James F List, Vincent Woo, Enrique Morales, Weihua Tang, Fred T Fiedorek. Diabetes Care 2009
20
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review.
Janet B McGill. Diabetes Ther 2014
Janet B McGill. Diabetes Ther 2014
20
Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trial.
P-M Schumm-Draeger, L Burgess, L Korányi, V Hruba, J E Hamer-Maansson, T W A de Bruin. Diabetes Obes Metab 2015
P-M Schumm-Draeger, L Burgess, L Korányi, V Hruba, J E Hamer-Maansson, T W A de Bruin. Diabetes Obes Metab 2015
20
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.
Seo Young Kim, James P Guevara, Kyoung Mi Kim, Hyon K Choi, Daniel F Heitjan, Daniel A Albert. Arthritis Care Res (Hoboken) 2010
Seo Young Kim, James P Guevara, Kyoung Mi Kim, Hyon K Choi, Daniel F Heitjan, Daniel A Albert. Arthritis Care Res (Hoboken) 2010
20
Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus.
Filippo Valbusa, Lorenzo Bertolini, Stefano Bonapace, Luciano Zenari, Giacomo Zoppini, Guido Arcaro, Christopher D Byrne, Giovanni Targher. Am J Cardiol 2013
Filippo Valbusa, Lorenzo Bertolini, Stefano Bonapace, Luciano Zenari, Giacomo Zoppini, Guido Arcaro, Christopher D Byrne, Giovanni Targher. Am J Cardiol 2013
20
Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
John P H Wilding, Vincent Woo, Norman G Soler, Andrea Pahor, Jennifer Sugg, Katja Rohwedder, Shamik Parikh. Ann Intern Med 2012
John P H Wilding, Vincent Woo, Norman G Soler, Andrea Pahor, Jennifer Sugg, Katja Rohwedder, Shamik Parikh. Ann Intern Med 2012
20
Uric acid is an important predictor for hypertensive early atherosclerosis.
Ruya Mutluay, Serpil Muge Deger, Eylem Bahadir, Alim Ozgur Durmaz, Riza Citil, Sukru Sindel. Adv Ther 2012
Ruya Mutluay, Serpil Muge Deger, Eylem Bahadir, Alim Ozgur Durmaz, Riza Citil, Sukru Sindel. Adv Ther 2012
20
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial.
K Strojek, K H Yoon, V Hruba, M Elze, A M Langkilde, S Parikh. Diabetes Obes Metab 2011
K Strojek, K H Yoon, V Hruba, M Elze, A M Langkilde, S Parikh. Diabetes Obes Metab 2011
20
Plasma uric acid and the risk of type 2 diabetes in a Chinese community.
Kuo-Liong Chien, Ming-Fong Chen, Hsiu-Ching Hsu, Wei-Tien Chang, Ta-Chen Su, Yuan-Teh Lee, Frank B Hu. Clin Chem 2008
Kuo-Liong Chien, Ming-Fong Chen, Hsiu-Ching Hsu, Wei-Tien Chang, Ta-Chen Su, Yuan-Teh Lee, Frank B Hu. Clin Chem 2008
20
Diabetes: Efficacy of dapagliflozin associated with renal function.
Rebecca Kirk. Nat Rev Endocrinol 2013
Rebecca Kirk. Nat Rev Endocrinol 2013
100
[Main causes of hyperuricemia in diabetes mellitus].
I V Madianov, M I Balabolkin, D S Markov, T N Markova. Ter Arkh 2000
I V Madianov, M I Balabolkin, D S Markov, T N Markova. Ter Arkh 2000
20
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.
Yukihiro Chino, Yoshishige Samukawa, Soichi Sakai, Yasuhiro Nakai, Jun-ichi Yamaguchi, Takeo Nakanishi, Ikumi Tamai. Biopharm Drug Dispos 2014
Yukihiro Chino, Yoshishige Samukawa, Soichi Sakai, Yasuhiro Nakai, Jun-ichi Yamaguchi, Takeo Nakanishi, Ikumi Tamai. Biopharm Drug Dispos 2014
20
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
Serge A Jabbour, Elise Hardy, Jennifer Sugg, Shamik Parikh. Diabetes Care 2014
Serge A Jabbour, Elise Hardy, Jennifer Sugg, Shamik Parikh. Diabetes Care 2014
20
Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology.
Sanjay Kalra. Diabetes Ther 2014
Sanjay Kalra. Diabetes Ther 2014
20
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Kamlesh Khunti, Marilia B Gomes, Stuart Pocock, Marina V Shestakova, Stéphane Pintat, Peter Fenici, Niklas Hammar, Jesús Medina. Diabetes Obes Metab 2018
Kamlesh Khunti, Marilia B Gomes, Stuart Pocock, Marina V Shestakova, Stéphane Pintat, Peter Fenici, Niklas Hammar, Jesús Medina. Diabetes Obes Metab 2018
20
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
20
Insulin Degludec, a Novel Ultra-Long-Acting Basal Insulin versus Insulin Glargine for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Wenchuan Zhou, Jinxin Tao, Xiaodong Zhou, Hongxia Chen. Diabetes Ther 2019
Wenchuan Zhou, Jinxin Tao, Xiaodong Zhou, Hongxia Chen. Diabetes Ther 2019
20
Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials.
Di Sun, Xu Zhang, Xiu-Xin Hou. Diabetes Technol Ther 2018
Di Sun, Xu Zhang, Xiu-Xin Hou. Diabetes Technol Ther 2018
20
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
M Monami, C Lamanna, N Marchionni, E Mannucci. Exp Clin Endocrinol Diabetes 2009
M Monami, C Lamanna, N Marchionni, E Mannucci. Exp Clin Endocrinol Diabetes 2009
20
Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery.
Heidi R Culver, John R Clegg, Nicholas A Peppas. Acc Chem Res 2017
Heidi R Culver, John R Clegg, Nicholas A Peppas. Acc Chem Res 2017
20
Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.
Julio Rosenstock, Denise Franco, Vadym Korpachev, Brad Shumel, Yuhui Ma, Robert Baughman, Nikhil Amin, Janet B McGill. Diabetes Care 2015
Julio Rosenstock, Denise Franco, Vadym Korpachev, Brad Shumel, Yuhui Ma, Robert Baughman, Nikhil Amin, Janet B McGill. Diabetes Care 2015
20
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes.
Robert Ritzel, Ronan Roussel, Andrea Giaccari, Jiten Vora, Claire Brulle-Wohlhueter, Hannele Yki-Järvinen. Diabetes Obes Metab 2018
Robert Ritzel, Ronan Roussel, Andrea Giaccari, Jiten Vora, Claire Brulle-Wohlhueter, Hannele Yki-Järvinen. Diabetes Obes Metab 2018
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.